Neoplasia/BPH

	Evaluating Treatment Effects with Patient-Response-Related Outcomes in Comparative Clinical Trials. NEJM Evid Mao L, Tian L, Huang B, Richardson PG, Ludmir EB, Hughes MD, Wei LJ. PMID: 41288427 [PubMed - indexed for MEDLINE]
	The One Big Beautiful Bill Act and the future of prostate cancer care. Cancer Grutman AJ, Pavlovich CP. PMID: 41288347 [PubMed - indexed for MEDLINE]
	Prognostic significance of magnetic resonance imaging-detected extraprostatic extension in localized prostate cancer. Cancer Kumar A, LaBella DA, Snider MC, Acklin-Wehnert SM, Gupta RT, Salama JK, Boyer MJ. PMID: 41288326 [PubMed - indexed for MEDLINE]
	A call for raising public awareness and improving outcomes of penile cancer. Cancer Aydin AM, Albersen M, Spiess PE. PMID: 41288247 [PubMed - indexed for MEDLINE]
	The burden of prostate cancer in Italy from 1990 to 2023, compared to the European Union and the Socio-Demographic Index (SDI) quintile countries: results from the Global Burden of Disease Study 2023. Minerva Urol Nephrol Passera R, Monasta L, Zamagni G. PMID: 41287862 [PubMed - as supplied by publisher]
	Surveillance Protocols After Nephrectomy or Ablation in Renal Cancer: A Scoping Review of Variations, Evidence, and Research Gaps. Cureus Adefehinti M, Agwu OR, Ahulu KT, Adedeji AB, Ndonga S, Makinde J, Jayeola A, Nedjim S. PMID: 41287785 [PubMed]
	Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer. J Clin Pharmacol Hadigol M, Williams JH, Shi H, Yang DZ, Hoffman J, Wang DD. PMID: 41287346 [PubMed - as supplied by publisher]
	Coptisine regulates PI3K/AKT pathway to block bladder cancer progression: a study based on network pharmacology, in vitro and in vivo assays. Hereditas Xiaohui Y, Jie L, Jiangqiao Z. PMID: 41287122 [PubMed - indexed for MEDLINE]
	Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma. Cancer Imaging Park JH, Choi D, Lee C, Kim CG, Kim S, Jung M, Yoon J. PMID: 41287074 [PubMed - as supplied by publisher]
	Correlation between metabolic unhealth and prostate cancer -an inverse probability weighting study. BMC Urol Chen M, Zhou Y, Wang J, Qiu H, An H, Tao N. PMID: 41286805 [PubMed - indexed for MEDLINE]
	LINC00332 as a potential diagnostic marker for the low-grade tumors in renal cell carcinoma patients. BMC Urol Taghehchian N, Maharati A, Taghavinia F, Golshan A, Salarzadeh S, Moghbeli M. PMID: 41286766 [PubMed - as supplied by publisher]
	Single-position intraperitoneal laparoscopic radical nephroureterectomy using a modified supine position. BMC Urol Han X, Zhou M, Xiong M, Xiao Y, Wu Y, Jiang H, Tu M, Wu S, Hou T. PMID: 41286721 [PubMed - indexed for MEDLINE]
	Rural variations in primary care prostate cancer diagnosis and survival: a cohort study using linked Australian primary care electronic medical record data. BMC Cancer Wawryk O, Collins IM, Lee A, Buzza M, Neil S, Freeman J, Emery J, Rafiq M. PMID: 41286674 [PubMed - in process]
	Recurrent mTOR pathway alterations in renal cell carcinoma with hemangioblastoma-like features: A multi-institutional study of 9 cases with expanding morphologic spectrum. Virchows Arch Zhao M, Yang X, Yin X, Ma T, Jin H, Xu J, Zhang H, Wang S. PMID: 41286520 [PubMed - as supplied by publisher]
	Nonexercise estimated cardiorespiratory fitness in relation to incidence of urinary tract, bladder and kidney cancer in the HUNT study. Sci Rep Khalil Y, Sun YQ, Mai XM. PMID: 41286400 [PubMed - as supplied by publisher]
	Quantitative synthetic MRI improves peripheral zone prostate cancer detection beyond PI-RADS v2.1. Int Urol Nephrol Wang Y, Sun H, Feng H, Xia C. PMID: 41286239 [PubMed - as supplied by publisher]
	Development and validation of mitochondrial metabolism-related genes in the prognostic and immunological characterization of clear cell renal cell carcinoma. Clin Exp Med Lu L, Jin J, Lu D, Peng Y, Fan Y. PMID: 41286149 [PubMed - indexed for MEDLINE]
	Under-Representation of Black and Hispanic Men in Metastatic Castration-Resistant Prostate Cancer Trials (2005-2021): A Call to Action. JCO Oncol Pract Dirican CD, Patel S, Al Mardini A, Sofia A, Fernandes BAC, Gondhi V, Maroules M. PMID: 41284949 [PubMed - as supplied by publisher]
	Lymph Node Invasion Prediction in Prostate Cancer: A Comparative Machine-Learning Study. Ann Surg Oncol Can O, Yücel Ö, Filtekin YC, Sa, , Aksoy K, Ötünçtemur A, Canat HL. PMID: 41284205 [PubMed - as supplied by publisher]
	Exosomal microRNAs as prostate cancer biomarkers and treatments: recent progress. Med Oncol Mahjoubin-Tehran M, Rezaei S. PMID: 41284143 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 297008

Page 1 of 14851



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy